Sunday, September 13, 2009

Ex-Cardinals Watch 9-13-09: Dmitri Young Improving; Chris Narveson Gets A Start; Joe Torre & Jason Marquis Look To Playoffs

Dmitri Young (Nationals):
Dmitri Young said he is recovering well from a torn left quadriceps and is in good health, but the veteran first baseman understands his career may be over.
Washington Times

Chris Narveson (Brewers):
That's changing in game No. 142. Left-handed reliever Chris Narveson will emerge from the bullpen to pinch-start for Manny Parra, still bothered by the neck spasms which had ended his most recent outing on Tuesday against St. Louis after one inning.
Brewers Official Site

Kevin Mulvey (Diamondbacks):
Rookie Kevin Mulvey, acquired from Minnesota on Sept. 1, was hit hard in his first career start. The right-hander had made two relief appearances for the Twins this season and two for the D-backs.

Mulvey (0-1) had barely gotten settled in on the mound before the Brewers jumped on top 1-0 in the first.

Milwaukee added two runs in the second and third innings and added one more before chasing Mulvey with two on and no one out in the fifth.
Diamondbacks Official Site

Max Scherzer (Diamondbacks):
Max Scherzer remains in uncharted territory.

The D-backs right-hander, who will start Sunday's series finale against the Brewers is in the final weeks of his first full season in the big leagues and his 154 innings pitched are the most he has thrown in his professional career.
Diamondbacks Official Site

Joe Torre (Dodgers MGR):
Owning a postseason managerial resume unparalleled in baseball history also means this isn't the first tight September stretch for Joe Torre, certainly far from it.
Dodgers Official Site

Jason Marquis (Rockies):
Even with a postseason berth on the line, injuries to a few Rockies starting pitchers will not force any extreme measures as the club sets its starting rotation for the final three weeks of the season.
Rockies Official Site

Dewon Brazelton (Camden):
The Camden Riversharks of the Atlantic League placed him on the inactive list.

No comments:

Post a Comment